Actively Recruiting
Comparison of Speech Understanding Between a Tonotopy-based Bimodal Fitting and a Default Bimodal Fitting in Newly Cochlear-implanted Patients: a Double-blind Randomized Crossover Study.
Led by MED-EL Elektromedizinische Geräte GesmbH · Updated on 2026-01-20
20
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating a new fitting strategy for people with profound bilateral deafness who use a cochlear implant (CI) combined with a hearing aid (HA) on the other ear, called bimodal hearing. The study compares a tonotopy-based fitting approach (TFS4), which matches electrode stimulation more closely to the cochlea's natural frequency layout, with a standard fitting method (FS4). The aim is to see if this new method improves speech understanding in noisy environments, as well as speech recognition in quiet and overall auditory skills. The study is a double-blind, randomized crossover trial where participants will use each fitting method for six weeks in a different order. One group starts with the default fitting (FS4) for six weeks then switches to the tonotopy-based fitting (TFS4) for six weeks, and the other group follows the reverse order. The cochlear implant settings are adjusted according to the assigned fitting strategy during these periods. Participants will be assessed at six weeks and twelve weeks after activation of the cochlear implant. During these visits, speech recognition in noise and quiet will be measured, along with evaluations of the auditory skills experienced by the participant. The trial is conducted at a single center, and the total study duration for each participant is twelve weeks of follow-up after activation. The sponsor is MED-EL Elektromedizinische Geräte GesmbH.
CONDITIONS
Brief Title
Comparison in New Cochlear Implanted Subjects of a Tonotopy-based Bimodal Fitting and a Conventional Fitting
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patient (>= 18 years old) speaking French
- Patient who fulfils the criteria for cochlear implantation
You will not qualify if you...
- Retro-cochlear pathology: auditory neuropathy, vestibular schwannoma
- Patient with residual hearing < 70 dB hearing level (HL) at 500 Hz and 1000 Hz on the contralateral ear
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants receive cochlear implant fitting with either a default strategy (FS4) or a tonotopy-based strategy (TFS4) in a randomized crossover design, switching after 6 weeks.
2 visits at 6 weeks and 12 weeks post-activation
Trial Site Locations
Total: 1 location
1
CHU Saint-Etienne
Saint-Etienne, France, 42055
Actively Recruiting
Research Team
V
Vincent Péan, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
OTHER
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here